Eli Lilly 2010 Annual Report Download - page 100

PROXY STATEMENT
Board of Directors
Directors’ Biographies
Class of 2011
The following four directors’ terms will expire at this year’s annual meeting. Each of these directors has been
nominated and is standing for election to serve a term that will expire in 2014. See “Item. 1 Election of Directors”
below for more information.
Michael L. Eskew Age 61 Director since 2008
Former Chairman and Chief Executive Officer, United Parcel Service, Inc.
Mr. Eskew served as chairman and chief executive officer of United Parcel Service, Inc., from
January 2002 until December 2007. He continues to serve on the UPS board of directors.
Mr. Eskew began his UPS career in 1972 as an industrial engineering manager and held
various positions of increasing responsibility, including time with UPS’s operations in
Germany and with UPS Airlines. In 1993, Mr. Eskew was named corporate vice president for
industrial engineering. Two years later he became group vice president for engineering. In
1998, he was elected to the UPS board of directors. In 1999, Mr. Eskew was named executive
vice president and a year later was given the additional title of vice chairman. He serves as
chairman of the board of trustees of The Annie E. Casey Foundation. Mr. Eskew also serves on
the boards of 3M Corporation and IBM Corporation.
Board Committees: audit (chair) and compensation
Alfred G. Gilman, M.D., Ph.D. Age 69 Director since 1995
Chief Scientific Officer, Cancer Prevention and Research Institute of Texas
Dr. Gilman is the chief scientific officer of the Cancer Prevention and Research Institute of
Texas and regental professor of pharmacology emeritus at the University of Texas
Southwestern Medical Center at Dallas. Dr. Gilman was on the faculty of the University of
Virginia School of Medicine from 1971 to 1981 and was named a professor of pharmacology
there in 1977. He previously served as executive vice president for academic affairs and
provost of the University of Texas Southwestern Medical Center at Dallas, dean of the
University of Texas Southwestern Medical School, and professor of pharmacology at the
University of Texas Southwestern Medical Center. He held the Raymond and Ellen Willie
Distinguished Chair of Molecular Neuropharmacology; the Nadine and Tom Craddick
Distinguished Chair in Medical Science; and the Atticus James Gill, M.D., Chair in Medical
Science at the university and was named a regental professor in 1995. He is a director of
Regeneron Pharmaceuticals, Inc. Dr. Gilman was a recipient of the Nobel Prize in Physiology
or Medicine in 1994.
Board Committees: public policy and compliance and science and technology (chair)
Karen N. Horn, Ph.D. Age 67 Director since 1987
Retired President, Private Client Services, and Managing Director, Marsh, Inc.
Ms. Horn serves as the board’s lead director. She served as president of private client
services and managing director of Marsh, Inc. from 1999 until her retirement in 2003. Prior to
joining Marsh, she was senior managing director and head of international private banking at
Bankers Trust Company; chairman and chief executive officer of Bank One, Cleveland, N.A.;
president of the Federal Reserve Bank of Cleveland; treasurer of Bell Telephone Company of
Pennsylvania; and vice president of First National Bank of Boston. Ms. Horn serves as director
of T. Rowe Price Mutual Funds; Simon Property Group, Inc.; and Norfolk Southern Corporation
and vice chairman of the U.S. Russia Foundation. She previously served on the board of Fannie
Mae and Georgia-Pacific Corporation. Ms. Horn has been senior managing director of Brock
Capital Group since 2004.
Board Committees: compensation (chair) and directors and corporate governance
6